Last update 26 Oct 2025

VEGFR vaccine restricted to HLA-A*0201(Osaka University)

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine
Synonyms
peptide vaccine for VEGFR1 & 2
Target
VEGFR1 x VEGFR2
Action
modulators
Mechanism
VEGFR1 modulators(Vascular endothelial growth factor receptor 1 modulators), VEGFR2 modulators(Vascular endothelial growth factor receptor 2 modulators)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication-
Inactive Indication
Advanced gastric carcinoma
Originator Organization
Osaka UniversityOsaka University
Active Organization-
Inactive Organization
Osaka UniversityOsaka University
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VEGFR vaccine restricted to HLA-A*0201(Osaka University)
JPRN-UMIN000005345
/ CompletedPhase 1/2IIT
Phase 1 & 2 clinical trial using peptide vaccine for VEGFR1 & 2 in combination with S-1 and Cisplatin for patients with advanced gastric cancer (HLA-A*0201) - Clinical trial of VEGFR vaccine with S-1 and Cisplatin (0201)
100 Clinical Results associated with VEGFR vaccine restricted to HLA-A*0201(Osaka University)
Login to view more data
100 Translational Medicine associated with VEGFR vaccine restricted to HLA-A*0201(Osaka University)
Login to view more data
100 Patents (Medical) associated with VEGFR vaccine restricted to HLA-A*0201(Osaka University)
Login to view more data
100 Deals associated with VEGFR vaccine restricted to HLA-A*0201(Osaka University)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced gastric carcinomaPhase 2
Japan
Osaka UniversityOsaka University
01 Jan 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free